Guangchun Han

18PUBLICATIONS
199CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyGene expression (incl. microarray and other genome-wide approaches)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Dec 02, 2025
GFER Represents a Target for Dual Disruption of Redox Homeostasis and Reactivation of the Immune Response in Pancreatic Adenocarcinoma.

Ziheng Chen, I-Lin Ho, Jintan Liu

|Nov 25, 2025
Nivolumab plus ipilimumab induce hyper-progression in renal medullary carcinoma: results of a phase II trial and preclinical evidence.

Melinda Soeung, Xinmiao Yan, Ciro Zanca

|Jan 10, 2025
Sitravatinib in combination with nivolumab plus ipilimumab in patients with advanced clear cell renal cell carcinoma: a phase 1 trial.

Pavlos Msaouel, Kai Yu, Ying Yuan

|Oct 07, 2024
Author Correction: Longitudinal single-cell profiling reveals molecular heterogeneity and tumor-immune evolution in refractory mantle cell lymphoma.

Shaojun Zhang, Vivian Changying Jiang, Guangchun Han

|Aug 24, 2024
METI: deep profiling of tumor ecosystems by integrating cell morphology and spatial transcriptomics.

Jiahui Jiang, Yunhe Liu, Jiangjiang Qin

|Mar 19, 2024
Author Correction: An atlas of epithelial cell states and plasticity in lung adenocarcinoma.

Guangchun Han, Ansam Sinjab, Zahraa Rahal

Pageof 3

Frequent Collaborators

18 joint publications

Linghua Wang

11 joint publications

P Andrew Futreal

7 joint publications

Shaojun Zhang

6 joint publications

Jianhua Zhang